However, mouse ACE2 does not efficiently bind the spike glycoprotein of either SARS-CoV-1 or SARS-CoV-2, rendering wild-type mice not useful in the study of SARS or COVID-19 pathogenesis, respectively, due to an inefficient ability to infect and replicate in host cells. This evidence concerns the gene ACE2 and COVID-19.